Epidemiology and outcome of bacterial meningitis in Canadian children

1998-1999

Entesar Husain, R. Chawla, S. Dobson, Herbert Dele Davies

Research output: Contribution to journalReview article

18 Citations (Scopus)

Abstract

Background: The introduction of Hemophilus influenzae type b (Hib) conjugate vaccine as part of the routine childhood vaccination schedule in Canada has resulted in a dramatic reduction in the cases of Hib meningitis. We describe the epidemiology and outcome of bacterial meningitis in Canadian children six years after the introduction of Hib conjugate vaccine and prior to the introduction of the conjugate Streptococcus pneumoniae vaccine. Methods: A retrospective chart review from January 1998 to December 1999 of children with meningitis identified at eight Canadian tertiary care children's hospitals belonging to the PICNIC network. Results: Bacterial meningitis was documented in 104 (11%) of 970 children presenting with meningitis. The most common isolated organisms were: Streptococcus pneumoniae (54%), group B streptococci (13%), and Neisseria meningitidis (11%). The mean age was 2.2 ± 3.5 yr. Forty seven percent of the children required admission to Intensive Care Unit (ICU), and 19% required artificial ventilation. Sequelae were documented among 32 children (31%) prior to discharge and there were 6 (5.6%) deaths attributable to meningitis and sepsis. Conclusions: Bacterial meningitis is an important cause of morbidity in Canadian children with S. pneumoniae replacing H. influenzae as the leading potentially vaccine preventable cause. Despite proper initiation of antimicrobial therapy, meningitis results in great morbidity and mortality in children in Canada.

Original languageEnglish (US)
Pages (from-to)131-135
Number of pages5
JournalClinical and Investigative Medicine
Volume29
Issue number3
StatePublished - Jun 1 2006

Fingerprint

Bacterial Meningitides
Epidemiology
Meningitis
Haemophilus influenzae type b
Streptococcus pneumoniae
Conjugate Vaccines
Canada
Vaccines
Morbidity
Child Mortality
Streptococcus agalactiae
Neisseria meningitidis
Haemophilus influenzae
Tertiary Healthcare
Intensive Care Units
Sepsis
Appointments and Schedules
Vaccination

ASJC Scopus subject areas

  • Medicine(all)

Cite this

Epidemiology and outcome of bacterial meningitis in Canadian children : 1998-1999. / Husain, Entesar; Chawla, R.; Dobson, S.; Davies, Herbert Dele.

In: Clinical and Investigative Medicine, Vol. 29, No. 3, 01.06.2006, p. 131-135.

Research output: Contribution to journalReview article

@article{5df917be7db5458cbb20840340a4596c,
title = "Epidemiology and outcome of bacterial meningitis in Canadian children: 1998-1999",
abstract = "Background: The introduction of Hemophilus influenzae type b (Hib) conjugate vaccine as part of the routine childhood vaccination schedule in Canada has resulted in a dramatic reduction in the cases of Hib meningitis. We describe the epidemiology and outcome of bacterial meningitis in Canadian children six years after the introduction of Hib conjugate vaccine and prior to the introduction of the conjugate Streptococcus pneumoniae vaccine. Methods: A retrospective chart review from January 1998 to December 1999 of children with meningitis identified at eight Canadian tertiary care children's hospitals belonging to the PICNIC network. Results: Bacterial meningitis was documented in 104 (11{\%}) of 970 children presenting with meningitis. The most common isolated organisms were: Streptococcus pneumoniae (54{\%}), group B streptococci (13{\%}), and Neisseria meningitidis (11{\%}). The mean age was 2.2 ± 3.5 yr. Forty seven percent of the children required admission to Intensive Care Unit (ICU), and 19{\%} required artificial ventilation. Sequelae were documented among 32 children (31{\%}) prior to discharge and there were 6 (5.6{\%}) deaths attributable to meningitis and sepsis. Conclusions: Bacterial meningitis is an important cause of morbidity in Canadian children with S. pneumoniae replacing H. influenzae as the leading potentially vaccine preventable cause. Despite proper initiation of antimicrobial therapy, meningitis results in great morbidity and mortality in children in Canada.",
author = "Entesar Husain and R. Chawla and S. Dobson and Davies, {Herbert Dele}",
year = "2006",
month = "6",
day = "1",
language = "English (US)",
volume = "29",
pages = "131--135",
journal = "Clinical and Investigative Medicine",
issn = "0147-958X",
publisher = "The Canadian Society for Clinical Investigation",
number = "3",

}

TY - JOUR

T1 - Epidemiology and outcome of bacterial meningitis in Canadian children

T2 - 1998-1999

AU - Husain, Entesar

AU - Chawla, R.

AU - Dobson, S.

AU - Davies, Herbert Dele

PY - 2006/6/1

Y1 - 2006/6/1

N2 - Background: The introduction of Hemophilus influenzae type b (Hib) conjugate vaccine as part of the routine childhood vaccination schedule in Canada has resulted in a dramatic reduction in the cases of Hib meningitis. We describe the epidemiology and outcome of bacterial meningitis in Canadian children six years after the introduction of Hib conjugate vaccine and prior to the introduction of the conjugate Streptococcus pneumoniae vaccine. Methods: A retrospective chart review from January 1998 to December 1999 of children with meningitis identified at eight Canadian tertiary care children's hospitals belonging to the PICNIC network. Results: Bacterial meningitis was documented in 104 (11%) of 970 children presenting with meningitis. The most common isolated organisms were: Streptococcus pneumoniae (54%), group B streptococci (13%), and Neisseria meningitidis (11%). The mean age was 2.2 ± 3.5 yr. Forty seven percent of the children required admission to Intensive Care Unit (ICU), and 19% required artificial ventilation. Sequelae were documented among 32 children (31%) prior to discharge and there were 6 (5.6%) deaths attributable to meningitis and sepsis. Conclusions: Bacterial meningitis is an important cause of morbidity in Canadian children with S. pneumoniae replacing H. influenzae as the leading potentially vaccine preventable cause. Despite proper initiation of antimicrobial therapy, meningitis results in great morbidity and mortality in children in Canada.

AB - Background: The introduction of Hemophilus influenzae type b (Hib) conjugate vaccine as part of the routine childhood vaccination schedule in Canada has resulted in a dramatic reduction in the cases of Hib meningitis. We describe the epidemiology and outcome of bacterial meningitis in Canadian children six years after the introduction of Hib conjugate vaccine and prior to the introduction of the conjugate Streptococcus pneumoniae vaccine. Methods: A retrospective chart review from January 1998 to December 1999 of children with meningitis identified at eight Canadian tertiary care children's hospitals belonging to the PICNIC network. Results: Bacterial meningitis was documented in 104 (11%) of 970 children presenting with meningitis. The most common isolated organisms were: Streptococcus pneumoniae (54%), group B streptococci (13%), and Neisseria meningitidis (11%). The mean age was 2.2 ± 3.5 yr. Forty seven percent of the children required admission to Intensive Care Unit (ICU), and 19% required artificial ventilation. Sequelae were documented among 32 children (31%) prior to discharge and there were 6 (5.6%) deaths attributable to meningitis and sepsis. Conclusions: Bacterial meningitis is an important cause of morbidity in Canadian children with S. pneumoniae replacing H. influenzae as the leading potentially vaccine preventable cause. Despite proper initiation of antimicrobial therapy, meningitis results in great morbidity and mortality in children in Canada.

UR - http://www.scopus.com/inward/record.url?scp=33745256737&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=33745256737&partnerID=8YFLogxK

M3 - Review article

VL - 29

SP - 131

EP - 135

JO - Clinical and Investigative Medicine

JF - Clinical and Investigative Medicine

SN - 0147-958X

IS - 3

ER -